proNGF inhibits proliferation and oligodendrogenesis of postnatal hippocampal neural stem/progenitor cells through p75NTR in vitro  by Guo, Jingjing et al.
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
www.e l sev i e r . com/ l oca te / sc r
Stem Cell Research (2013) 11, 874–887proNGF inhibits proliferation and
oligodendrogenesis of postnatal
hippocampal neural stem/progenitor
cells through p75NTR in vitro
Jingjing Guoa, Jianing Wanga, Chunrong Liangb, Jun Yana, Yeran Wangb,
Gaoxiang Liu a, Zhenzhou Jianga, Luyong Zhanga, Xiaobin Wangc,
Yanjiang Wangb, Xinfu Zhoud, Hong Liaoa,e,⁎a Neurobiology Laboratory, Jiangsu Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, China
b Department of Neurology and Center for Clinical Neuroscience, Daping Hospital,
Third Military Medical University, Chongqing 400042, China
c Laboratory Animal Center, Southeast University, Nanjing 210009, China
d School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, SA 5000, Australia
e State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China
Received 26 September 2012; received in revised form 2 May 2013; accepted 7 May 2013
Available online 21 May 2013Abstract Neural stem/progenitor cells (NSCs) proliferate and differentiate under tight regulation by various factors in the
stem cell niche. Recent studies have shown that the precursor of nerve growth factor (NGF), proNGF, abounds in the central
nervous system (CNS) and that its expression level in the brain is substantially elevated with aging as well as in several types of
CNS disorders. In this study, we found for the first time that proNGF inhibited the proliferation of NSCs isolated from postnatal
mouse hippocampus and caused cell cycle arrest in the G0/G1 phase without affecting apoptosis. In addition, proNGF reduced
the differentiation of NSCs to oligodendrocytes. The effects of proNGF were blocked by the fusion protein of p75 neurotrophin
receptor extracellular domain and human IgG Fc fragment (p75NTR/Fc), and by p75NTR knockout, suggesting that proNGF/
p75NTR interaction was involved in the effects of proNGF on NSC proliferation and differentiation. proNGF decreased the
phosphorylation level of extracellular signal responsive kinase 1/2 (ERK 1/2) in a p75NTR-dependent manner under both
self-renewal and differentiation conditions. The inhibition of ERK 1/2 phosphorylation by U0126 significantly reduced the
proliferation and oligodendrogenesis of NSCs, indicating that ERK 1/2 inhibition by proNGF partially explains its effects on NSC
proliferation and oligodendrogenesis. These results suggest that the proNGF/p75NTR signal plays a key role in the regulation of
NSCs' behavior.
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5-bromo-2-deoxyuridine; TUNEL, terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling; ERK, extracellular signal
responsive kinase.
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875Effects of proNGF on hippocampal NSCs via p75NTRIntroduction
Neural stem/progenitor cells (NSCs) proliferate and differenti-
ate throughout life to maintain the constant size of the NSC
pool and to produce newly born cells for reparation of CNS
injury. These processes are tightly regulated by various factors
from themicroenvironment/nichewhere NSCs reside (Wurmser
et al., 2004). The elucidation of potential signaling molecules
regulating NSC activity in the niche may contribute not only to
the understanding of neurogenesis but also to the development
of new therapies for nervous system disorders.
The unprocessed precursor of nerve growth factor (NGF),
proNGF, has been demonstrated to actually be the predominant
form of NGF in CNS (Fahnestock et al., 2001). It has emerged
from studies in the past decade that proNGF has distinct
functions with respect to NGF, besides acting chaperone-like
for NGF folding during its biogenesis. Unlike NGF, which is
well-known for its beneficial effects on cell survival, pro-
liferation, and neurite outgrowth (Cattaneo and McKay, 1990;
Wang et al., 2009), proNGF has been mostly shown to induce
apoptosis of various types of cells under pathological conditions
including seizures and spinal cord injury, where its expression is
elevated (Volosin et al., 2008; Beattie et al., 2002). Further-
more, an elevated proNGF level was observed in the brains of
old rodents and patients with Alzheimer's disease (Al-Shawi et
al., 2008; Pedraza et al., 2005; Terry et al., 2011). proNGF was
postulated to be accumulated in the hippocampus which
contains a population of NSCs with a decreased ability to
generate new cells. These studies prompted us to investigate
whether proNGF constitutes a potential factor that regulates
the activity of hippocampal NSCs.
The p75 neurotrophin receptor (p75NTR) has been identi-
fied as the common receptor for neurotrophins and proneuro-
trophins. As it lacks an intrinsic ligand-inducible enzymatic
activity, p75NTR functions through either the collaboration
with co-receptors, the recruitment of intracellular signaling
proteins or the release of its intracellular domain via secretase-
dependent proteolysis (Hempstead, 2002). p75NTR is in-
volved in multiple cellular responses including cell apoptosis,
survival, neurite outgrowth, migration, and cell cycle arrest
through the activation of various downstream signaling
pathways (Hempstead, 2002; Cragnolini and Friedman,
2008). Recent studies have identified the expression of
p75NTR in NSCs from the subventricular zone and progenitor
cells in dentate gyrus, and have proposed that p75NTR
deficiency perturbed NSC proliferation and differentiation in
response to neurotrophins (Bernabeu and Longo, 2010; Young
et al., 2007). These observations suggested that p75NTR
signaling might be involved in regulating the proliferation and
differentiation of NSCs. Moreover, studies have already
confirmed that proNGF, among the neurotrophin family,
preferentially binds p75NTR with high affinity and initiates
apoptosis in several neuronal subpopulations (Lee et al.,
2001). Our previous studies suggest that proNGF retards
neurite outgrowth in both neuronal cell lines and primary
neuron through p75NTR (Wang et al., 2010). Furthermore, it is
well established that p75NTR is substantially increased under
pathological conditions that are known to induce proNGF
expression (Chakravarthy et al., 2012; Podlesniy et al., 2006).
Therefore, it is reasonable to investigate whether proNGF/
p75NTR interaction plays a role in regulating the behaviors of
NSCs.In this study, the results showed that proNGF inhibited NSC
proliferation and reduced their differentiation to oligoden-
drocyte in a p75NTR-dependent manner, which involved inhi-
bition of the ERK 1/2 signaling pathway.
Materials and methods
Cell culture
All animal tests were carried out in accordance with the US
National Institute of Health (NIH) Guide for the Care and Use of
Laboratory Animals published by the US National Academy of
Sciences (http://oacu.od.nih.gov/regs/index.htm). All ex-
perimental procedures were approved by the Administration
Committee of Experimental Animals, Jiangsu Province and
China Pharmaceutical University.
NSCs were isolated from the hippocampus of newborn pups
(postnatal day 1, C57BL/6J strain) of wild type and p75NTR
knock-out mice (p75NTRExonIII−/− mice, Jackson lab, West
Grove, PA, USA) following previously described methods with
some modifications (Shetty and Turner, 1998). In brief, whole
hippocampi were dissected, dissociated in Accutase Cell Dis-
sociation Reagent (Invitrogen, Carlsbad, CA, USA) and seeded in
the proliferation medium consisting of DMEM/F12, B27 (2%,
Invitrogen), bFGF (20 ng/ml, Invitrogen), EGF (20 ng/ml,
Invitrogen) and 1% penicillin–streptomycin. Cells proliferated
and formed neurospheres after 3–4 days of culture. After one
or two passages, cells were used in the subsequent experi-
ments. In the assays for multipotency, single cells dissociated
fromneurospheres were plated in 24-well plates with coverslips
pre-coated with poly-D-lysine (PDL, Sigma-Aldrich, St Louis,
MO, USA) and laminin (Invitrogen), and were cultured in DMEM/
F12 containing 2% B27 and 1% FBS to help the differentiation of
cells.
Primary rat hippocampal neurons were cultured following
methods described previously (Volosin et al., 2008). Cells
isolated from the hippocampus of rat fetuses (embryonic day
18, E18) were plated on poly-L-lysine (PLL, Sigma)-coated
24-well plates and maintained in Neurobasal™ medium
(Invitrogen) supplemented with 2% B27 and Glutamax (1%,
Invitrogen) for four days before treatment.
Cell viability assay
Single dissociated NSCs were plated in replicates of four in
96-well plates at a density of 7000 cells per well in 100 μl
DMEM/F12 containing 2% B27, 10 ng/ml EGF and 10 ng/ml
bFGF. Cells were treated with proNGF (0.4–2 nM in PBS,
cleavage-resistant mutated form, human; Alomone, Israel)
for 24 h or 48 h with PBS as a control, or U0126 (1 and 10 μM,
in 0.2% DMSO; Beyotime, Jiangsu, China) for 48 h with DMSO
(0.2%) as a control. Cell proliferation was quantified using a
CellTiter-Glo Luminescent Cell Viability Assay kit (Promega,
Madison, WI, USA) according to the manufacturer's protocol.
BrdU incorporation assay
Single dissociated cells were plated in 24-well plates
with PLL-coated coverslips and cultured with DMEM/F12
containing 2% B27, 10 ng/ml EGF and 10 ng/ml bFGF.
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to the cultures 36 h before fixation. Nuclei that incorporated
BrdU in this time-window were detected by immunofluores-
cence as described below. The cell proliferation rate was
represented by the percentage of BrdU-positive cells (total
number of BrdU-positive cells / total cell number evaluated
by Hoechst staining).
Neurosphere assay
Dissociated NSCswere plated at a density of 100,000 cells/ml in
uncoated 35-mm dishes. Cells were cultured in proliferation
medium with or without 2 nM proNGF for 24 h and 48 h. At the
end of the culture, five random viewfields of each group were
captured using an Olympus microscope (New Hyde Park, NY,
USA, http://www.olympus.com/), and the diameters of neuro-
spheres were measured using Image-Pro Plus software (Media
Cybernetics, Silver Spring, MD). The assay was conducted in
triplicate.
TUNEL assay
Cells were plated on PLL-coated coverslips and were treated
with PBS control or 2 nM proNGF for 48 h. Cells were then
processed for TUNEL analysis (Roche Molecular Biochemi-
cals, Indianapolis, IN, USA) and counterstained with Hoechst
33342 to visualize nuclei. TUNEL-positive cells of at least 10
random viewfields containing more than 2000 cells were
counted for each culture condition.
Cell cycle assay
Cells in G1/G0, S, and G2/M phases of the cell cycle can be
discriminated by analysis of DNA ploidy (Darzynkiewicz and
Juan, 2001; Nunez, 2001). Here, the measurement of cellular
DNA content and the analysis of cell cycle were performed
using propidium iodide (PI) staining and flow cytometry.
Briefly, NSCs were dissociated and fixed in ice-cold 70%
ethanol. After washing with PBS, cells were resuspended in
PBS containing 50 μg/ml PI (Sigma) and 10 μg/ml RNase A
(Beyotime). Cell suspensions were then incubated at 37 °C for
30 min and then transferred to FACS Calibur flow cytometry
(BD Biosciences, Franklin Lakes, NJ, USA, http://www.
bdbiosciences.com/). PI fluorescence was measured and the
percentage of cells existing within various phases in the cell
cycle was analyzed using ModFit software (http://www.vsh.
com/products/mflt/index.asp). Data from a minimum of
10,000 cells per sample were collected.
Reverse-transcription PCR and real-time PCR
Total mRNA of NSCs was isolated using TRIzol Reagent
(Invitrogen). RNA was reverse-transcribed using the
RevertAid™ First Strand cDNA Synthesis Kit (Fermantas,
Amherst, NY, USA) with oligodT. PCR was performed with
GoTaq Flexi DNA Polymerase (Promega). Amplified PCR
products were analyzed by electrophoresis on a 1% agarose
gel. For real-time PCR, an abundance of each mRNA sample
was quantified using the corresponding primers and the
SYBR® Premix Ex Taq™II (Takara, Japan). Gene expressionswere normalized by β-actin and represented as a relative
transcription level to those in the PBS-treated group. PCR
primer sets were shown in Supplementary Table S1.Western blot
Protein samples from cells and tissues were extracted using
RIPA buffer (Beyotime) supplemented with a protease in-
hibitor cocktail (Roche, Indianapolis, IN, USA). Equal amounts
of extracts from different preparations were separated on
SDS-polyacrylamide gels and subjected to immunoblotting.
Primary antibodies against the extracellular domain of
p75NTR (rabbit, 1:1000, a gift from Professor Moses Chao of
New York University), the cytoplasmic domain of p75NTR
(rabbit, 1:700, Promega), sortilin (rabbit, 1:1000, Abcam),
TrkA (rabbit, 1:1000, Abcam), caspase-3 (rabbit, 1:1000, Cell
Signaling Technology, Beverly, MA, USA), cyclin D1 (rabbit,
1:1500, Cell Signaling Technology), cyclin E (rabbit, 1:800,
Cell Signaling Technology), p-ERK1/2 (rabbit, 1:1000, Cell
Signaling Technology), total ERK1/2 (rabbit, 1:1000, Cell
Signaling Technology), p-Akt (rabbit, 1:1000, Cell Signaling
Technology), Akt (rabbit, 1:1000, Cell Signaling Technology),
p-STAT3 (rabbit, 1:1500, Cell Signaling Technology), STAT3
(rabbit, 1:1500, Cell Signaling Technology), β-tubulin III
(mouse, 1:800, Chemicon, Temecula, CA, US), GFAP (rabbit,
1:2000, DAKO, Copenhagen, Denmark), CNPase (mouse, 1:
1000, Sigma), NG2 (rabbit, 1:600, Chemicon), nestin (mouse,
1:500, Chemicon) and β-actin (mouse, 1:3000, Sigma) were
used. To detect the phosphorylated protein and total protein
of ERK 1/2, Akt and STAT3, blots were probed with antibodies
against the phosphorylated protein, stripped and then re-
probed for total protein. Immunoreactive bands were visual-
ized by incubation with Horseradish peroxidase (HRP)-conju-
gated secondary antibodies and detection using ECL
(Pierce, Rockford, IL, USA). Relative expression levels of
proteins were quantified using Quantity One software
(Bio-Rad).Immunocytochemistry
Cells on coverslips were processed for immunocytochemistry
as previously described (Liao et al., 2008). Primary antibodies
against BrdU (mouse, 1:200, Santa Cruz Biotechnology, CA,
USA), nestin (mouse, 1:200, Chemicon), β-tubulin III (mouse,
1:300, Chemicon), GFAP (rabbit, 1:500, DAKO), CNPase
(mouse, 1: 800, Sigma), NG2 (rabbit, 1:300, Chemicon),
p75NTR intracellular domain (rabbit, 1:700, Promega) and
p75NTR extracellular domain (rabbit, 1:1000, a gift from
Professor Mose Chao of New York University) were used. Then
samples were incubated with Alexa Fluor 488 and/or
Cy3-conjugated secondary antibodies (1:300, Invitrogen),
counterstained with Hoechst 33342 to label all cell nuclei
and mounted in fluorescent mounting medium. For the BrdU
assay, cells were incubated in 2 N HCl for 30 min at room
temperature before blocking. The fluorescence imaging was
visualized by using an Olympus fluorescence microscope (New
Hyde Park, NY, USA, http://www.olympus.com/). At least
2000 cells from 10 to 15 viewing fields per group were used to
calculate the percentage of cells.
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Statistical analysis was carried out with Graph Pad Prism 5
software (Graph Pad Software Inc., San Diego, CA). Data were
presented as a mean ± SEM of at least three independent
experiments. For experiments with more than two groups,
results were compared using one-way analysis of variance
(ANOVA) with post hoc Tukey's test. For two group-designed
experiments, comparisons were performed using unpaired
Student's t-test. A p-value of b0.05 was considered statistically
significant.Results
proNGF inhibited NSC proliferation without inducing
any apoptosis
Dissociated NSCs were maintained in proliferation medium
during 24 or 48 hour blocks with or without proNGF (0.4 nM,
2 nM, 10 nM, respectively). The results of cell viability assay
demonstrated that proNGF induced a significant reduction in
viable cell number (Fig. 1A), which may have resulted from a
decrease in the proliferation and/or induction of cell apopto-
sis. To investigate whether proNGF inhibited NSC proliferation,
BrdU incorporation assay and neurosphere assay were per-
formed. As shown in Figs. 1B and C, the percentage of
BrdU-labeled cells was decreased by about one fifth in theFigure 1 proNGF inhibits the proliferation of hippocampal NSCs w
diluted proNGF for 24 h or 48 h followed by an assessment of cell
BrdU-incorporating cells (BrdU, red; Hoechst, blue). (C) proNGF redu
(D) proNGF induces apoptosis of rat embryonic hippocampal neurons
Hoechst, blue). (E) Percentages of TUNEL-positive cells among total
caspase-3 in NSCs. The error bars in bar graphs represent SEM of t
**p b 0.01, ***p b 0.001 compared with PBS group. N.S., no significapresence of 2 nM proNGF for 48 h (p b 0.001), and the
neurosphere size was significantly reduced by proNGF
treatment for 24 and 48 h blocks, suggesting that proNGF
exerted an inhibitory effect on NSC proliferation.
Mounting evidence has presented proNGF as a potential
inducer of cell apoptosis in several types of neural cells
(Hempstead, 2009). To explore the possibility that the decrease
in viable cells was partially attributed to elevated cell apo-
ptosis, we performed terminal deoxynucleotidyl transferase-
mediated biotinylated UTP nick end labeling (TUNEL) assay
which reflects apoptosis-associated DNA strand breaks. As
shown in Figs. 1D and E, no significant difference in TUNEL-
positive cells was observed between PBS- and proNGF-treated
NSCs (p N 0.05). Furthermore, proNGF did not impact the
cleavage of caspase-3 in NSCs, a critical step in inducing cell
apoptosis (Fig. 1F). As it has been reported that proNGF induced
apoptosis of hippocampal neurons both in vitro and in vivo
(Volosin et al., 2008), we exposed hippocampal neurons derived
from E18 rat fetus to proNGF (2 nM) for 48 h. The proportion of
TUNEL-positive neurons was increased by around three folds
after proNGF treatment (Figs. 1D and E), which was in line with
previous studies. Taken together, proNGF inhibited the prolif-
eration of NSCs without inducing apoptosis.
proNGF retarded cell cycle progression
The cell cycle is involved in the regulation of cell growth. PI
staining and flow cytometry were applied to monitor theithout inducing apoptosis. (A) NSCs were treated with serially
viability assay. (B) proNGF (2 nM) reduced the percentage of
ced the diameters of neurospheres after 24 and 48 h in culture.
but not that of NSCs, as shown by TUNEL assay (TUNEL, green;
cells were calculated. (F) proNGF did not impact the cleavage of
hree (C, E, F) or five (B) independent experiments. *p b 0.05,
nt difference. Scale bar = 50 μm.
878 J. Guo et al.allocation of cells to different cell cycle phases under
self-renewing conditions in the presence or absence of 2 nM
of proNGF for 24 and 48 h. Compared with PBS control,
proNGF treatment increased the percentage of cells in the
G0/G1 phase at the expense of the S-phase (Figs. 2A and B). No
statistically significant difference in the G2/M phase distribu-
tion was noted between the two groups (Fig. 2C).
Cell cycle progression is tightly controlled by a series of
regulators. Both cyclin D1 and cyclin E accelerate G1-to-S
transition. Real-time PCR and western blot analyses revealed
that proNGF treatment reduced the expression of cyclin E at
both mRNA (Fig. 2G) and protein levels (Figs. 2H and I) by more
than 40% and 20% respectively. However, neither mRNA nor the
protein expression level of cyclin D1 was significantly affected
by proNGF (Figs. 2D–F). These results imply that proNGF
probably inhibits NSC proliferation by arresting cells at the G0/
G1 phase.Figure 2 proNGF retards the cell cycle progression of hippocampa
NSCs in G0/G1 phase (A) while reducing their distribution in S phase (B)
groups (C). Real-time PCR analysis demonstrated that proNGF did not
cyclin E in NSCs (G). Immunoblotting of cyclin D1 (E) and cyclin E (H
expression at the protein level. β-Actin was used as a loading contro
cyclin E (I). Data were shown as means ± SEM of three independent exproNGF inhibited NSC proliferation in a
p75NTR-dependent manner
p75NTR is the high-affinity receptor for proNGF, as first
proposed by Ramee Lee et al. (2001). To explore whether
p75NTR signaling was involved in the effect of proNGF on
NSC proliferation, we first tested the expression of p75NTR
in NSCs. mRNA and protein expression of p75NTR in NSCs
were detected by RT-PCR and western blot respectively,
with mouse brain lysate as a positive control (Figs. 3A and B).
A protein band for p75NTR was absent in NSCs from
p75NTR-knockout mice (Fig. 3B). The immunostaining
demonstrated that p75NTR colocalized with the stem cell
marker nestin in neurospheres (Fig. 3C-a), which was further
confirmed on dissociated NSCs using antibodies against the
extracellular (Fig. 3C-b) and the intracellular domain
(Fig. 3C-c) of p75NTR. The specificity of antibodies againstl NSCs. proNGF significantly increased the relative distribution of
. No significant differencewas found in G2/M distribution between
impact the expression levels of cyclin D1 (D) but it downregulated
) in NSCs extracts showed consistent effects of proNGF on their
l. Bar graphs show the relative protein levels of cyclin D1 (F) and
periments. *p b 0.05, **p b 0.01 between groups.
Figure 3 proNGF inhibits NSC proliferation in a p75NTR-dependent manner. (A) RT-PCR analysis revealed the expression of p75NTR in
NSCs, with mouse brain extracts as a positive control. (B) Protein lysates from NSCs and wild-type mouse brain were probed for the
presence of p75NTR using antibody against the extracellular domain of p75NTR. Note that a protein band for p75NTR was absent in
p75NTR-knockout NSCs. (C) Double immunostaining with antibodies against the extracellular domain of p75NTR (green) and nestin (red)
demonstrated the expression of p75NTR on NSCs spheres (a) and dissociated cells (b). (c) Another antibody raised against the intracellular
domain of p75NTR was applied to further confirm the expression of p75NTR on dissociated NSCs. Cell nuclei were all counterstained by
Hoechst (blue). (D) p75NTR/Fc (140 nM) partially reversed the inhibitory effect of proNGF (2 nM) on NSC proliferation as shown by the
fluorescence micrographs of BrdU immunostaining (BrdU, red; Hoechst, blue). (E) BrdU incorporation rate in wild-type and
p75NTR-deficient NSCs was quantified following proNGF (2 nM) treatment for 48 h (BrdU, red; Hoechst, blue), which showed no effect
of proNGF on the proliferation of p75NTR-deficient NSCs. Values in bar graphs represent the mean ± SEM from three independent
experiments. *p b 0.05, **p b 0.01, ***p b 0.001 between groups. Scale bar = 50 μm. Abbreviations: WT, wild type; p75-KO,
p75NTR-knockout; p75ECD, p75NTR extracellular domain; p75ICD, p75NTR intracellular domain.
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western blot as shown in Supplementary Fig. S1.
We next investigated the functional interaction between
proNGF and p75NTR in NSCs. The fusion molecule of p75NTRextracellular domain and human IgG Fc fragment (p75NTR/
Fc) was used to scavenge proNGF from the culture medium.
p75NTR/Fc has been shown to be efficient in antagonizing
the pro-apoptotic effect of proNGF on neurons (Wang et al.,
880 J. Guo et al.2010). Cells were exposed to proNGF (2 nM) alone and
together with p75NTR/Fc (140 nM) for 48 h. As shown in
Fig. 3D, the addition of p75NTR/Fc largely reversed the effect
of proNGF on NSC proliferation (p b 0.001, vs. proNGF group).
However, p75NTR/Fc alone had no effect on the proliferation
(p N 0.05, vs. PBS group). To provide further evidence for the
involvement of p75NTR in proNGF-induced inhibition of cell
proliferation, NSCs derived from p75NTR-knockout mice were
treated with proNGF (2 nM) for 48 h. In contrast to wild-type
NSCs, p75NTR-deficient NSCs displayed minimal difference in
the BrdU incorporation rate after proNGF treatment (Fig. 3E).
Together, these results point to a critical role of p75NTR in
mediating the inhibitory effect of proNGF on NSC proliferation.proNGF suppressed ERK1/2 phosphorylation
which affected NSC proliferation under
self-renewal condition
Several signaling pathways including MEK/ERK 1/2, PI3K/Akt
and JAK/STAT3 are involved in NSC proliferation according to
previous studies (Migita et al., 2008; Kang and Kang, 2008).We
next explored the possible involvement of these signaling
pathways in the effect of proNGF on NSC proliferation. As
shown in Fig. 4A, resting NSCs obtained by starvation in a
growth factor-free medium displayed a prompt increase in
ERK 1/2 phosphorylation level within 30 min, upon the stimu-
lation by the proliferation medium containing EGF and bFGF.
proNGF (2 nM) treatment transiently suppressed the phos-
phorylation of ERK 1/2 (p b 0.05, vs. PBS group, Figs. 4B and
C). However, no significant difference was found in the
phosphorylation level of Akt and STAT3 between PBS- and
proNGF-treated groups (Supplementary Fig. S2). We then
focused on the ERK 1/2 signaling in subsequent experiments.
The inhibitory effect of proNGF on ERK 1/2 activation was
partially reversed by simultaneous p75NTR/Fc (140 nM) treat-
ment (p b 0.05, vs. proNGF group, Figs. 4D and E). Nonethe-
less, proNGF (2 nM) failed to decreased the phosphorylation
level of ERK 1/2 in p75NTR-knockout NSCs compared with PBS
control (p N 0.05, vs. PBS group, Figs. 4G and H), even though
similar activation of ERK 1/2 was observed upon proliferation
(Fig. 4F).
To confirm the role of ERK 1/2 inhibition in NSC proli-
feration, NSCs were treated with U0126, a selective inhibitor
of MEK 1/2, the kinase immediately upstream of ERK 1/2.Figure 4 proNGF inhibits ERK1/2 phosphorylation through p75NTR un
showed that the phosphorylation level of ERK1/2 in NSCs varied with tim
containing EGF and bFGF. (B) Quiescent NSCs were treated with or witho
detect ERK1/2 phosphorylation levels. (C) The densitometric quantifi
30 min. (D) Representative immunoblots showed p-ERK 1/2 and total
together with p75NTR/Fc (140 nM) upon proliferation. (E) The densitom
effect of proNGF on ERK 1/2 activation. (F) ERK 1/2 phosphorylation
proliferation. (G) proNGF did not impact ERK 1/2 phosphorylation in
western blot results (H). (I) U0126 (in 0.2% DMSO) at various concent
CellTiter-Glo cell viability assay. 0.2% DMSO was used as a solvent contr
incorporation rate of NSCs (BrdU, red; Hoechst, blue). (K) Representative
1/2 phosphorylation in NSCs at the indicated time points after the initia
SEM from three independent experiments. *p b 0.05, **p b 0.01, ***p b 0
group (I and J). Scale bar = 50 μm. Abbreviations: p75-KO, p75NTR-knocCellTiter-Glo cell viability assay and BrdU incorporation assay
were performed 48 h later to assess NSC proliferation. As
shown in Figs. 4I and J, various concentrations of U0126 sig-
nificantly inhibited NSC proliferation. Ten micromolar of
U0126 caused a remarkable decrease in the phosphorylation
level of ERK 1/2 upon proliferation (Fig. 4K). Taken together,
these results imply that inhibition of ERK 1/2 phosphorylation
by proNGF through p75NTR under the self-renewal condition
accounted, at least to some extent, for the effect of proNGF
on NSC proliferation.proNGF changed the lineage fate of NSCs
To investigate the effect of proNGF on NSC differentiation,
we cultured dissociated NSCs in PDL/laminin-coated 24-well
plates with DMEM/F12 containing B27 and 1% FBS for seven
days. As shown in Figs. 5A and B, the percentage of β-tubulin
III-positive (a specific marker of neuron) cells was not
affected, while a slight increase of GFAP-positive (a specific
marker of astrocyte) cells was observed. Interestingly, the
percentage of NG2-positive (a specific marker of immature
oligodendrocyte) and CNPase-positive (a specific marker of
mature oligodendrocyte) cells were decreased by about one
third and one fourth respectively compared with PBS
control, resulting in a significant reduction in total oligo-
dendrocytes (the sum of NG2- and CNPase-positive cells) in
the proNGF-treated group (p b 0.05, compared with the PBS
group). Consistently, the expression of GFAP, β-tubulin III,
CNPase and NG2 at protein level was modulated to a similar
extent in NSCs in response to 2 nM proNGF treatment
(Fig. 5C).
Next, mRNA expression levels of several lineage-restricted
genes were determined after a 24-hour or a 4-day differen-
tiation. In addition to GFAP and nestin, Olig1, Olig2 and Ngn1
mRNAs were also evaluated, among which the former two
encode proteins that are essential for oligodendrogenesis,
with the latter being for neurogenesis in CNS. As shown in
Fig. 5D, Olig2 mRNA levels were reduced by about 60% while
GFAP mRNA was elevated by about 50% in proNGF-treated
cells, compared with PBS control at 24 h after differentiation.
On the fourth day of exposure to proNGF, Olig1 mRNA de-
creased by about 40% (Fig. 5E). However, there were no
statistically significant differences in nestin and Ngn 1 mRNA
levels between the two groups.der the self-renewal condition. (A) Representative immunoblotting
e after the resting cells were transferred to proliferation medium
ut 2 nM proNGF in proliferationmedium followed by western blot to
cation showed that proNGF inhibited ERK 1/2 phosphorylation at
ERK 1/2 expressions in NSCs treated with proNGF (2 nM) alone or
etric quantification revealed that p75NTR/Fc partially reversed the
levels in p75NTR-knockout NSCs at the indicated time points to
p75NTR-deficient NSCs, as revealed by quantitative analysis from
rations significantly inhibited NSC proliferation as determined by
ol. (J) U0126 (10 μM, in 0.2% DMSO) dramatically reduced the BrdU
immunoblots showed the inhibitory effect of U0126 (10 μM) on ERK
tion of cell proliferation. Values in bar graphs represent the mean ±
.001 between groups (C and E) or compared with the DMSO control
kout.
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Figure 5 proNGF changes the lineage fate of NSCs. (A) After being differentiated for seven days in the presence of 2 nM proNGF, NSCs
showed a slight increase in the percentages of GFAP-positive astrocytes (a, green) and a significant decrease in CNPase- (b, red) and NG2-
(b, green) positive oligodendrocytes, but no changes in β-tubulin III-positive neurons (a, red). Nuclei were counterstained with Hoechst (a
and b, blue). (B) Bar graphs showed the percentages of immuno-positive cells. (C) Immunoblotting showed the effects of proNGF on
protein levels of GFAP, β-tubulin III, CNPase and NG2 in NSCs after a 7-day differentiation. β-Actin was used as a loading control.
Real-time PCR was performed to determine the relative transcript levels of lineage-restricted genes in NSCs after the differentiation for
24 h (D) and 4 days (E). Values in bar graphs represent the mean ± SEM from three independent experiments. *p b 0.05, **p b 0.01,
***p b 0.001 between groups. Scale bar = 50 μm.
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p75NTR-dependent manner
The above results demonstrated that proNGF caused a
prominent change in the proportion of oligodendrocyte
lineage. To determine whether p75NTR mediated the effect
of proNGF on the differentiation of NSCs to oligodendro-
cyte, NSCs were treated with both p75NTR/Fc and 2 nM
proNGF. p75NTR/Fc (140 nM) largely recovered the reduc-
tion of NG2-positive cells caused by proNGF (p b 0.05, vs.
proNGF group, Figs. 6A and B). However, such an effect was
not observed in CNPase-positive cells (p N 0.05, vs. proNGF
group, Figs. 6A and C). p75NTR deficiency depleted the
response of NSCs to proNGF under the differentiation
conditions. Interestingly, p75NTR deficiency per se resulted
in a significant decrease in both immature and mature
oligodendrocytes (p b 0.001, vs. PBS group of wild-type
cells, Figs. 6D–F). These observations support the notionthat p75NTR is essential for the effect of proNGF on
oligodendrocyte differentiation.
proNGF inhibited ERK 1/2 phosphorylation through
p75NTR upon differentiation
It has been reported that ERK1/2 phosphorylation is involved
in growth factor-mediated oligodendrocyte lineage differen-
tiation and increases Olig2 expression at early stages of
oligodendrogenesis (Hu et al., 2008). Thus, the effect of
proNGF on the phosphorylation of ERK1/2 under the differen-
tiation conditions was investigated. After being cultured in
DMEM/F12 medium without B27 and FBS supplements for 1 h,
the differentiation of NSCs was induced by replacing the
culture medium with DMEM/F12 containing B27 and 1% FBS,
which led to a remarkable increase of ERK 1/2 phosphorylation
levels (Fig. 7A). proNGF transiently inhibited ERK1/2 phos-
phorylation at 10 min (p b 0.05, vs. PBS group, Figs. 7B and C)
Figure 6 proNGF inhibits oligodendrogenesis in a p75NTR-dependent manner. (A) Double immunostaining of NG2 (green) and
CNPase (red) showed a restoration of oligodendrogenesis in proNGF-treated NSCs in the presence of p75NTR/Fc (140 nM), which was
added simultaneously with proNGF to block its binding to p75NTR. Nuclei were stained with Hoechst (blue). Statistical analysis was
shown in (B) and (C). (D) proNGF did not impact the percentages of NG2 (green) - and CNPase (red) -positive cells in p75NTR-knockout
NSCs. Nuclei were stained with Hoechst (blue). Statistical analysis was shown in (E) and (F). *p b 0.05, **p b 0.01, ***p b 0.001
between groups. Values in bar graphs represent the mean ± SEM from three independent experiments. Scale bar = 50 μm.
Abbreviations: WT, wild type; p75-KO, p75NTR-knockout; p75/Fc, p75NTR/Fc.
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of ERK 1/2 activation (p b 0.01, vs. proNGF group, Figs. 7D and
E). The phosphorylation of ERK 1/2 in p75NTR-knockout NSCs
was also elevated upon differentiation, but was not affected
by proNGF treatment (Figs. 7F–H), indicating that the
inhibition of proNGF on ERK 1/2 phosphorylation is dependent
on p75NTR signaling.
To investigate whether ERK 1/2 played an essential role in
oligodendrogenesis, NSCs were differentiated in the presence
of U0126 for seven days. As shown in Figs. 7I and J, application
of U0126 significantly reduced the proportions of NG2- and
CNPase-positive cells, and increased the proportion of GFAP-
positive cells compared with DMSO solvent control. However,
the proportions of β-tubulin III-positive cells were not af-
fected. A positive relationship between the inhibitory
effect of U0126 on oligodendrogenesis and its concentra-
tion was observed. Notably, the phosphorylation level of
ERK 1/2 was dramatically decreased by the presence of
U0126 (10 μM) in the differentiation medium (Fig. 7K).
Collectively, these data suggest that the inhibition of ERK
1/2 phosphorylation possibly contributed to the effect of
proNGF on oligodendrogenesis.Discussion
In the present study, our data provide the first evidence of
the critical role of proNGF in regulating the proliferation and
differentiation of hippocampal NSCs from postnatal mice.
To evaluate the effects of proNGF on NSC proliferation, we
performed cell viability assay, BrdU incorporation assay and
neurosphere assay. Our results showed that proNGF signifi-
cantly reduced the total number of viable cells and the
proportion of BrdU-positive cells, as well as the neurosphere
size, suggesting that proNGF exerted an inhibitory role on NSC
proliferation. Proliferation is intimately controlled by a pro-
gression in the cell cycle. Mitogenic control of proliferation
occurs early in G1, allowing cells to bypass the first decision
point (R1) in this cycle when a cell may either continue to
proliferate or exit the cell cycle (Lange et al., 2009). The
results of flow cytometry demonstrate that proNGF increases
the distribution of cells in the G1/G0 phase at the expense of
the S phase and downregulates the expression of cyclin E, an
important positive regulator driving cells to pass the G1 phase.
These findings are in accordance with the inhibitory effect of
proNGF on NSC proliferation.
884 J. Guo et al.Our data showed that proNGF reduced the proportion of
oligodendrocyte lineage after NSCs differentiated, accompa-
nied by a slight increase in the proportion of astrocytes.
However, the ratio of neurons was not substantially changed.Previous reports have shown that transcription factors regulate
cell-type-specific differentiation during CNS development.
Olig1 and Olig2, two basic helix–loop–helix (bHLH) transcrip-
tion factors, are believed to facilitate oligodendrogenesis
885Effects of proNGF on hippocampal NSCs via p75NTRduring CNS development (Rowitch et al., 2002). Moreover,
downregulation of Olig2 has been shown to cause a switch from
an oligodendrocyte to an astrocyte fate in neural stem cells
(Zhu et al., 2012). In this study, Olig2 and Olig1 were found to
be downregulated under the differentiation conditions after
24-hour and 4-day treatments of proNGF respectively, indicat-
ing that proNGF might inhibit oligodendrogenesis partially
through regulating the expression of oligodendrocyte lineage-
specific transcription factors.
p75NTR, initially recognized as a low-affinity pan-receptor
for the neurotrophin family, has been demonstrated to
preferentially bind proNGF with the highest specificity and
affinity (Lee et al., 2001). Recently, several studies have
provided evidence for the involvement of p75NTR in NSC
proliferation and differentiation. It was proposed that p75NTR
defined a discrete population of highly proliferative SVZ
precursor cells and that the absence of p75NTR disrupted
neurotrophin-regulated neurogenesis in vivo (Young et al.,
2007). p75NTR deficiency also significantly decreased the
number of BrdU-positive cells in the hippocampus of adult
mice (Bernabeu and Longo, 2010). In addition, p75NTR is
essential for the action of BDNF and NT3 on oligodendrocyte
differentiation (Du et al., 2006). In this study, we confirmed
the expression of p75NTR on hippocampal NSCs in culture. The
addition of p75NTR/Fc fusion protein into the culture medium
as a scavenger of proNGF significantly reversed its effects on
NSC proliferation and oligodendrocyte differentiation. More-
over, deletion of the ligand-binding extracellular domain of
p75NTR abolished the responsiveness of NSCs to proNGF. These
results demonstrated an important role of proNGF/p75NTR
interaction in the functions of proNGF. It is interesting to note
that p75NTR deficiency resulted in a remarkable decrease in
NSC proliferation and oligodendrogenesis, which is consistent
with previous studies (Bernabeu and Longo, 2010; Du et al.,
2006). It is likely that p75NTR deficiency depletes the ben-
eficial effects of certain ligands such as NGF and NT3 secreted
by NSCs themselves, which has been shown to promote NSC
proliferation and oligodendrogenesis. Another possibility is
that p75NTR functions in a ligand-independent manner which
might be inhibited by proNGF binding as proposed by Bredesen
and Rabizadeh (1997). However, neither p75NTR deficiency
(data not shown) nor proNGF treatment exerted an obvious
effect on neurogenesis, which seems to be contradictory toFigure 7 proNGF inhibits ERK 1/2 phosphorylation through p75
showed that the phosphorylation level of ERK1/2 in NSCs varied w
ERK1/2 phosphorylation in NSCs at 10 min after differentiation, as r
with proNGF (2 nM) alone and together with p75NTR/Fc (140 nM)
densitometric analysis showed that ERK 1/2 phosphorylation could b
(F) Immunoblotting showed a similar phosphorylation of ERK1/2 in p
impact ERK 1/2 phosphorylation in p75NTR-knockout NSCs at the
densitometric analysis in (H). (I) Effects of U0126 at various c
immunostaining with antibodies against GFAP (green, upper panel),
NG2 (green, lower panel). Cells were counterstained with Hoechst
U0126 treatment caused a significant increase in the percentag
CNPase-positive oligodendrocytes. No impacts were found in the num
that U0126 (10 μM) dramatically inhibited ERK 1/2 phosphorylation
differentiation. Data were shown as a mean ± SEM of three indepen
groups (C and E) or compared with 0 μM U0126 group (K). &&& and ##
group. Scale bar = 50 μm. Abbreviations: p75-KO, p75NTR-knockoutprevious observations on SVZNSCs (Young et al., 2007). It might
be partially explained by a relatively low level of neuron
differentiation in our experimental condition. Alternatively,
NSCs from different regions of the brain are not all equivalent
and have specific responses to stimulators (Thiriet et al., 2011).
Furthermore, the downstream signaling pathways of p75NTR
are so complicated that proNGF may induce quite different
responses from those induced by mature neurotrophins.
Although p75NTR has been correlated to the proliferation
and differentiation of NSCs, the underlying molecular mech-
anisms remain undefined. ERK 1/2 activation has been shown
to be responsible for the proliferation and oligodendrogenesis
of NSCs, and to be able to promote cell cycle progression and
Olig2 expression (Wang et al., 2009; Hu et al., 2008), which led
us to investigate whether or not ERK 1/2 signaling pathway is
regulated by proNGF/p75NTR interaction in NSCs. Using
western blotting techniques, we observed that quiescent
NSCs showed an increased phosphorylation level of ERK 1/2
upon the induction of proliferation and differentiation.
Intriguingly, proNGF transiently inhibited the phosphorylation
of ERK 1/2, which was demonstrated to be mediated by
p75NTR. Both the proliferation of NSCs and their differenti-
ation to oligodendrocyte were strongly inhibited when ERK 1/2
phosphorylation was impaired by U0126, suggesting that the
ERK 1/2 signaling pathway played a critical role in the
proliferation and lineage fate determination of NSCs. These
results raised the possibility that the inhibition of ERK 1/2
signal by proNGF partially accounted for its negative regula-
tion of NSC proliferation and oligodendrogenesis. It has been
shown that proNGF prevented ERK 1/2 activation induced by
BDNF in basal forebrain cholinergic neurons (Volosin et al.,
2006). Furthermore, downregulation of p75NTR in mesence-
phalic dopaminergic neurons caused a prominent increase in
the ERK 1/2 phosphorylation level, while a high expression
level of p75NTR was accompanied by ERK 1/2 inhibition,
indicating that ERK 1/2 phosphorylation might be inhibited by
p75NTR (Alavian et al., 2009). However, Masoudi et al. showed
that proNGF is capable of activating TrkA/ERK 1/2 in primed
PC12 cells which highly express TrkA although p75NTR is also
present (Masoudi et al., 2009). Considering the fact that
proNGF exerts various effects depending on the presence of
co-receptors of p75NTR and their balance, we performed
western blot to detect the expression of sortilin and TrkA onNTR under the differentiation conditions. (A) Immunoblotting
ith time after differentiation. (B) proNGF transiently inhibited
evealed by densitometric analysis in (C). (D) NSCs were treated
and ERK 1/2 phosphorylation level was determined. (E) The
e partially recovered by a combined treatment with p75NTR/Fc.
75NTR-knockout NSCs after differentiation. (G) proNGF did not
indicated time points after differentiation, as shown by the
oncentrations on NSC differentiation were demonstrated by
β-tubulin III (red, upper panel), CNPase (red, lower panel) and
(blue). (J) Quantification of immuno-positive cells showed that
e of GFAP-positive astrocytes and a reduction in NG2- and
ber of β-tubulin III-positive neurons. (K) Immunoblotting showed
in NSCs at the indicated time points after the initiation of cell
dent experiments. *p b 0.05, **p b 0.01, ***p b 0.001 between
# (K), p b 0.001 compared with each corresponding 0 μM U0126
.
886 J. Guo et al.NSCs. As shown in Fig. S4, both receptors were expressed by
NSCs, with a relatively low expression level of TrkA compared
to neonate mouse brain lysate. Therefore, it is likely that the
inhibitory effect of proNGF on ERK 1/2 activation in NSCs can
be attributed to either a high p75NTR/TrkA expression ratio,
the presence of certain as-yet-unidentified p75NTR co-
receptors or particular intracellular signaling molecules,
which remains to be further investigated.
Many studies have shown that neurogenesis is impaired in
the hippocampus of aging and AD brains, resulting in memory
loss and cognition deficit, although controversy still exists
(Lazarov and Marr, 2010; Rodriguez et al., 2008). In addition,
white matter damage due to oligodendrocyte degeneration
and insufficient oligodendrogenesis was considered to account
for the pathology of some CNS diseases including AD, spinal
cord injury, and multiple sclerosis (Desai et al., 2010; Yune et
al., 2007; Keough and Yong, 2012). Increased expression of
proNGF and p75NTR has been shown to induce cell death
under these pathological conditions (Ibanez and Simi, 2012). A
recent study has shown that non-peptide, small molecules
that blocked proNGF/p75NTR interaction has promoted
functional recovery after spinal cord injury (Tep et al.,
2013). Therefore, the pharmacological intervention on
proNGF/p75NTR signaling might be a promising approach not
only in promoting neural cell survival, but also in regulating
NSC proliferation and facilitating themyelination process, and
thus promoting desired outcomes. In the end, due to the
complexity of the in vivo conditions, the effects of proNGF on
NSC proliferation and differentiation should be scrutinized on
the basis of in vivo models so as to provide more valuable
information for the potential of blocking proNGF/p75NTR
interaction in the treatment of CNS disorders.
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